Half-year report · HY
7317.TEDINET S100X0JU
Period2025-04-01 → 2025-09-30
Filed2025-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.5bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥9.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.9bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥1.0bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.1bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.1bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.1bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥861m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.6bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥796m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥861m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥796m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥11.0bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥10.9bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥11.0bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.1bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥4.0bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥6.9bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.9bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.2bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.2bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.1bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥4.1bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.0bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.2bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥809m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.4bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥154m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥746m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥414m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥295m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥38m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥34m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥40.34 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥73.38 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.49 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥40 | 2025-04-01 → 2025-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥72.55 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥37.05 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 62.8% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.6% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.0% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2025-04-01 → 2025-09-30 | ¥92m |
| Otherother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥92m |
| Otherother segments | segment profit | 2025-04-01 → 2025-09-30 | −¥19m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥183m |
| Medical Healthcarereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥3.1bn |
| Medical Healthcarereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥3.1bn |
| Medical Healthcarereportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥975m |
| Safetysystemreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥1.4bn |
| Safetysystemreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥1.4bn |
| Safetysystemreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥254m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥4.5bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥4.5bn |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥1.2bn |
| Otherother segments | revenue | 2024-04-01 → 2024-09-30 | ¥77m |
| Otherother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥77m |
| Otherother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥25m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥152m |
| Medical Healthcarereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| Medical Healthcarereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| Medical Healthcarereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥924m |
| Safetysystemreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| Safetysystemreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| Safetysystemreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥265m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥4.9bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥4.9bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥1.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 475
| Item | Context | Value | Unit |
|---|---|---|---|
| Repayments of lease obligations fin cf | Prior1InterimDuration | -21777000 | JPY |
| Repayments of lease obligations fin cf | InterimDuration | -26874000 | JPY |
| Other net fin cf | Prior1InterimDuration | 2773000 | JPY |
| Other net fin cf | InterimDuration | -1326000 | JPY |
| Net cash provided by used in financing activities | Prior1InterimDuration | 33665000 | JPY |
| Net cash provided by used in financing activities | InterimDuration | -295243000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1InterimDuration | 43012000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | InterimDuration | -231419000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1InterimDuration | 1045903000 | JPY |
| Net increase decrease in cash and cash equivalents | InterimDuration | 128285000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 2171278000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 3983027000 | JPY |
| Cash and cash equivalents | Prior1InterimInstant | 3217181000 | JPY |
| Cash and cash equivalents | InterimInstant | 4111312000 | JPY |
| Employee payrolls and allowances sga | Prior1InterimDuration | 131545000 | JPY |
| Employee payrolls and allowances sga | InterimDuration | 129119000 | JPY |
| Provision for bonuses sga | Prior1InterimDuration | 13236000 | JPY |
| Provision for bonuses sga | InterimDuration | 14869000 | JPY |
| Retirement benefit expenses sga | Prior1InterimDuration | 3764000 | JPY |
| Retirement benefit expenses sga | InterimDuration | 4005000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E35560-000MedicalHealthcareReportableSegmentMember | 2983269000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E35560-000SafetysystemReportableSegmentMember | 1872145000 | JPY |
| Revenues from external customers | Prior1InterimDuration_OtherReportableSegmentsMember | 76782000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReportableSegmentsMember | 4932198000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1InterimDuration | 4932198000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E35560-000MedicalHealthcareReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E35560-000SafetysystemReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_OtherReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration | － | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E35560-000MedicalHealthcareReportableSegmentMember | 2983269000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E35560-000SafetysystemReportableSegmentMember | 1872145000 | JPY |
| Net sales | Prior1InterimDuration_OtherReportableSegmentsMember | 76782000 | JPY |
| Net sales | Prior1InterimDuration_ReportableSegmentsMember | 4932198000 | JPY |
| Net sales | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1InterimDuration | 4932198000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E35560-000MedicalHealthcareReportableSegmentMember | 924266000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E35560-000SafetysystemReportableSegmentMember | 265206000 | JPY |
| Operating income | Prior1InterimDuration_OtherReportableSegmentsMember | 25407000 | JPY |
| Operating income | Prior1InterimDuration_ReportableSegmentsMember | 1214880000 | JPY |
| Operating income | Prior1InterimDuration_ReconcilingItemsMember | -152303000 | JPY |
| Operating income | Prior1InterimDuration | 1062577000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E35560-000MedicalHealthcareReportableSegmentMember | 3064183000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E35560-000SafetysystemReportableSegmentMember | 1382622000 | JPY |
| Revenues from external customers | InterimDuration_OtherReportableSegmentsMember | 92392000 | JPY |
| Revenues from external customers | InterimDuration_ReportableSegmentsMember | 4539197000 | JPY |
| Revenues from external customers | InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | InterimDuration | 4539197000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |